| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.091 | 0.05 |